Total Funding
19
57
Total FundingPost-IPO Debt raised
Growth Score 19 in past quarter
-1 pts
Heat Score 57 in past quarter
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
244282
Biotechnology company engaged in the extraction and distribution of psychoactive compounds, and developing natural health care products.
- Alexzander Samuelsson: Founder and Chief Research Officer
About the Company
HAVN Life Sciences is a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs, the development of natural health products, and innovative therapies to support central nervous system health and enhance the capabilities of the mind.